Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call

Operator: Good morning, and welcome to Oncolytics Biotech's Third Quarter 2023 Conference Call. All participants are now in listen-only mode.

Related Keywords

Canada , Canadian , Roche Incyte , Jon Patton , Thomas Heineman , Matt Coffey , Louise Chen , Tom Heineman , John Newman , Nasdaq , Global Head Of Business Development , Oncolytics Biotech Inc , Oil Refinery Stocks To , European Society For Medical Oncology , Oncolytics Biotech , Call Transcript November , Third Quarter , Investor Relations , Chief Medical Officer , Global Head , Business Development , Andrew De Guttadauro , Chief Financial Officer , Kirk Look , European Society , Medical Oncology , Registrational Trials , Precision Promise Phase , Chief Medical , Precision Promise , Registrational Studies , Oil Refinery Stocks To Buy , Small Cap Biotech Stocks , Massive Potential According ,